Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Shortland

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Quarterly Journal of Medicine|July 1, 1972
Renal disease in partial lipodystrophyA J Eisinger, J R Shortland, P J Moorhead
International Journal of Experimental Pathology|December 1, 1991
The relationship between donor age and the growth characteristics of human smooth muscle cultures of aorta and stomachR D Start, R S Loomes, J R Shortland
Histopathology|December 1, 1989
Immunohistochemistry and lectin histochemistry in sarcomatoid renal cell carcinoma: a comparison with classical renal cell carcinomaS C Harris, P M Hird, J R Shortland
Genitourinary Medicine|June 1, 1989
Electron microscopy to differentiate intestinal spirochaetosis from other conditionsK M Roberts, D W Cotton, J R Shortland
Cancer|May 1, 1971
Lymphosarcoma of the lung with monoclonal (IgM) gammopathy. A clinicopathologic, histochemical, immunologic, and ultrastructural studyA M Ward, J R Shortland, C S Darke
Postgraduate Medical Journal|August 29, 2001
CalciphylaxisR V Mathur, J R Shortland, A M el-Nahas
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2001
Calciphylaxis with facial involvementR V Mathur, J R Shortland, A M El Nahas
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Can immunosuppressive drugs slow the progression of IgA nephropathy?D Goumenos, M Ahuja, J R Shortland, et al.
Ciba Foundation Symposium|January 1, 1980
Methods for the study of lung metabolismH F Woods, A Meredith, G T Tucker, et al.
Nephron|January 1, 1989
Irreversible renal failure following mefenamic acidJ Boletis, A J Williams, J R Shortland, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Quarterly Journal of Medicine|July 1, 1972
Renal disease in partial lipodystrophyA J Eisinger, J R Shortland, P J Moorhead
International Journal of Experimental Pathology|December 1, 1991
The relationship between donor age and the growth characteristics of human smooth muscle cultures of aorta and stomachR D Start, R S Loomes, J R Shortland
Histopathology|December 1, 1989
Immunohistochemistry and lectin histochemistry in sarcomatoid renal cell carcinoma: a comparison with classical renal cell carcinomaS C Harris, P M Hird, J R Shortland
Genitourinary Medicine|June 1, 1989
Electron microscopy to differentiate intestinal spirochaetosis from other conditionsK M Roberts, D W Cotton, J R Shortland
Cancer|May 1, 1971
Lymphosarcoma of the lung with monoclonal (IgM) gammopathy. A clinicopathologic, histochemical, immunologic, and ultrastructural studyA M Ward, J R Shortland, C S Darke
Postgraduate Medical Journal|August 29, 2001
CalciphylaxisR V Mathur, J R Shortland, A M el-Nahas
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2001
Calciphylaxis with facial involvementR V Mathur, J R Shortland, A M El Nahas
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Can immunosuppressive drugs slow the progression of IgA nephropathy?D Goumenos, M Ahuja, J R Shortland, et al.
Ciba Foundation Symposium|January 1, 1980
Methods for the study of lung metabolismH F Woods, A Meredith, G T Tucker, et al.
Nephron|January 1, 1989
Irreversible renal failure following mefenamic acidJ Boletis, A J Williams, J R Shortland, et al.
Pageof 5